Clinical Trials Directory

Trials / Completed

CompletedNCT00743704

Novel Noninvasive Techniques to Study Neutrophil Airway Inflammation in an Ozone Challenge Model

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
15 (estimated)
Sponsor
Fraunhofer-Institute of Toxicology and Experimental Medicine · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

The primary objective of this pilot study is to establish a model of neutrophil airway inflammation for future testing of anti-inflammatory substances in an early stage of clinical development. Moreover, the suitability of an electronic nose for early detection and diagnosis of airway inflammation will be determined.

Detailed description

Experimental ozone exposure of human subjects is known to induce transient neutrophilic airway inflammation with sputum neutrophilia and elevated concentrations of inflammatory mediators in bronchoalveolar lavage and sputum supernatants. In this study, ozone at a concentration of 250 ppb will be inhaled for three hours in an ozone challenge chamber. In a recent study, ozone challenge has been discussed as a model for pulmonary diseases dominated by neutrophilic inflammation such as COPD, providing the possibility to test new anti-inflammatory substances in early stages of clinical development.

Conditions

Interventions

TypeNameDescription
OTHERozoneexposuresubjects will be exposed to either ozone (250 ppb) or filtered air in an ozone challenge chamber for three hours. Ventilation will be increased to 20 l/min/m2 by intermittent exercise on a bicycle ergometer.

Timeline

Start date
2008-08-01
Primary completion
2009-03-01
Completion
2009-04-01
First posted
2008-08-29
Last updated
2009-04-21

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT00743704. Inclusion in this directory is not an endorsement.